« Zurück
Home /
PD153035 (Hydrochloride)

PD153035 (Hydrochloride)

ArtNr	HY-12013-10mM
Hersteller	MedChem Express
CAS-Nr.	183322-45-4
Menge	10mM/1mL
Quantity options	100 mg 10mM/1mL 10 mg 50 mg 5 mg
Kategorie	Neuroscience Metabolism Diabetes Cholesterol & Lipid Metabolism Regulation of Appetite Neural Signaling Inhibitors & Compound Libraries Small Molecules
Typ	Inhibitors
Specific against	other
Purity	98.78
Formula	C16H15BrClN3O2
Citations	bioRxiv. 2024 Apr 4.<br/>Biochim Biophys Acta Mol Basis Dis. 2023 Dec 13:166981.<br/>Cell Death Dis. 2022 Jul 25;13(7):647.<br/>Elife. 2015 Feb 10;4:e05178.<br/>Gen Comp Endocrinol. 2020 Dec 1;299:113616.<br/>Int J Stem Cells. 2022 Jun 30.<br/>J Toxicol Sci. 2023 Nov 14;48(12):655-663.<br/>Nat Commun. 2018 Jun 5;9(1):2174.<br/>[1]Bridges AJ, et al. Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor. J Med Chem. 1996 Jan 5;39(1):267-76.<br/>[2]Fry DW, et al. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science. 1994 Aug 19;265(5175):1093-5.<br/>[3]Bos M, et al. PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptoractivation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin Cancer Res. 1997 Nov;3(11):2099-106.<br/>[4]Kunkel MW, et al. Inhibition of the epidermal growth factor receptor tyrosine kinase by PD153035 in human A431 tumors in athymic nude mice. Invest New Drugs. 1996;13(4):295-302.
Smiles	COC1=C(C=C(C2=C1)N=CN=C2NC3=CC(Br)=CC=C3)OC.Cl
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	SU-5271 (Hydrochloride); AG1517 (Hydrochloride); ZM 252868 (Hydrochloride)
Lieferbar
Product Description	PD153035 Hydrochloride (SU-5271 Hydrochloride) is a potent EGFR inhibitor with Ki and IC50 of 6 and 25 pM, respectively.
StorageTemperature	4°C (Powder, sealed storage, away from moisture)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	396.67
Clinical Information	No Development Reported
Manufacturers Research Area	Cancer
Solubility	DMSO : 5.125 mg/mL (ultrasonic; warming)\|H2O : < 0.1 mg/mL (ultrasonic; warming; heat to 60°C)
Target	EGFR
Manufacturers Target	EGFR
Isoform	EGFR/ErbB1/HER1
Manufacturers Pathway	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Manufacturers Product type	Reference compound

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkdatenblatt anfordern

HY-12013-10mM-safety-datasheet.pdf